FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

Spoonful of sugar gives sports drinks run for money Nov 29, 8:35 am
Washington D.C, Nov 29 (ANI): Energy drinks may have ran out of fizz as a team of scientists has discovered that a spoonful of sugar in water has the same effect.
Full Story
`Skunk-like` weed risks your brain Nov 29, 8:14 am
Washington D.C, Nov 29 (ANI): You may want to avoid smoking skunk-like weed as a new study shows that high potency cannabis can damage a crucial part of the brain responsible for communication between the two brain hemispheres.
Full Story
NGO AVYS praised for collection 7000 units of blood from Arunachal Nov 27, 12:00 pm
Itanagar, Nov. 27 (ANI): Arunachal Pradesh's Civil Aviation and Transport Minister Jomde Kena has lauded the Arunachal Vivekananda Yuva Shakti (AVYS) for its continued humanitarian service.
Full Story
Western BP guidelines may put Asians at stroke risk Nov 27, 8:03 am
Washington D.C, Nov 27 (ANI): The recent Western blood pressure guidelines may actually boost the stroke risk if used for Asian patients, particularly the elderly, according to an expert opinion.
Full Story